Preliminary evaluation of the hypolipidemic effects in man of a new phenolic ether (Su-13437, CIBA)

Hess, 1968, Hypolipidaemic properties of a new tetralin derivative (CIBA 13,437-Su), Experientia (Basel), 24, 418, 10.1007/BF02144360

Best, 1968, Lipid effects of a tetralin phenoxy isobutyric acid, Circulation, 38, 2

Thorp, 1962, Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate, Nature (Lond.), 194, 948, 10.1038/194948a0

Best, 1964, Hypolipemia and hepatomegaly from ethyl chlorophenoxyisobutyrate (CPIB) in the rat, J. Lab. clin. Med., 64, 634

Abell, 1959, A simple method for the estimation of total cholesterol and demonstration of its specificity, J. biol. Chem., 195, 357, 10.1016/S0021-9258(19)50907-3

Duncan, 1968, Influence of a terminal period of fasting on the serum and tissue lipid effects of ethyl chlorophenoxyisobutyrate (CPIB), Metabolism, 17, 681, 10.1016/0026-0495(68)90052-8

Van Handel, 1957, Micromethod for the direct determination of serum triglycerides, J. Lab. clin. Med., 50, 152

Bartlett, 1959, Phosphorus assay in column chromatography, J. biol. Chem., 234, 466, 10.1016/S0021-9258(18)70226-3

Best, 1966, Effects of Clofibrate and dextrothyroxine singly and in combination on serum lipids, Arch. intern. Med. (Chic.), 118, 97, 10.1001/archinte.1966.00290140001001